8-K8.019.01
8-K exhibit
EDGARTheravance Biopharma Inc (TBPH) SEC filings
Theravance Biopharma Inc (TBPH) SEC filings — 10-K, 10-Q, 8-K, and Form 4 as cached from EDGAR. When an exhibit lands, this page shows the headline, the numbers, and why it matters.
Those exhibit numbers sit next to the income-statement cache: Latest reported TBPH revenue for 2025-09-30 was $20.0M. Net income was $44.9M. Revenue was down 23.7% from 2025-06-30 to 2025-09-30. TBPH currently screens at market cap $861.5M and trailing P/E 7.5. The TBPH filings page is the source view; the stock page is the research view.
EDGAR remains the official archive. Lician caches 8-K exhibits so you can read what Theravance Biopharma Inc said without waiting on a live EDGAR scrape. Item 2.02 is the earnings exhibit — this page prefers EX-99.1 revenue, growth, EPS, and guidance over a form-type label. Form 4 insider prints stay on the same ticker timeline.
0
10-K
0
10-Q
5
8-K
0
Form 4
Recent filings
EDGAR is the official archive. Browse all TBPH filings.
Frequently asked questions
What did TBPH just say?
TBPH cached filings are listed below. Open the latest 8-K exhibit for the company’s own words.
Where are TBPH SEC filings?
5 cached filings are on this page. EDGAR remains the official archive (CIK 0001583107).
What is an 8-K Item 2.02?
Item 2.02 is the earnings exhibit. Lician reads EX-99.1 for revenue, growth, EPS, and guidance — not a form-type label.